Bristol-Myers Squibb Company
Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making
Last updated:
Abstract:
Compounds represented by formula (I) ##STR00001## can be used to make antibody-drug conjugates. The conjugates so made are stable in both human and mouse serum, enabling the performance of pre-clinical studies using a mouse model.
Status:
Grant
Type:
Utility
Filling date:
29 May 2019
Issue date:
26 Jan 2021